Semax peptides 10mg 10vials

Description

Semax Nootropic ACTH Analog for Cognitive Enhancement Research

Mode of Action

The biochemical activity of Semax is characterized by its non-hormonal interaction with the melanocortin system and neurotrophic factor regulation. Initially, the peptide functions as an agonist at the melanocortin receptor 4 (MC4R) within the brain. This defines the first semantic triple: [Semax activates MC4R]. Additionally, the molecule rapidly induces the expression of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in the hippocampus and cerebral cortex. This establishes the second triple: [Semax stimulates neurotrophic factor expression]. Furthermore, Semax prevents the breakdown of endogenous enkephalins by inhibiting the enzymes responsible for their degradation. This forms the third triple: [Semax inhibits enkephalinase activity]. Quantitatively, Semax demonstrates a systemic half-life of approximately 1.5 to 2 hours in research models. Comparative analysis shows that while Selank focuses on anxiolytic GABAergic modulation, Semax prioritizes cognitive arousal and neuroprotection against ischemic stress.

About This Compound

Semax is a synthetic heptapeptide analog of the adrenocorticotropic hormone (ACTH) fragment 4-10, specifically the Met-Glu-His-Phe-Pro-Gly-Pro sequence. This neuropeptide operates as a potent modulator of the central nervous system by bypassing traditional hormonal pathways to directly influence neuroplasticity and metabolic resilience. Unlike native fragments, the addition of a Pro-Gly-Pro tripeptide to the C-terminus significantly enhances its proteolytic stability and blood-brain barrier permeability.

Chemical Properties

• CAS Number: 80714-61-0
• Molecular Formula: C37H51N9O10S
• Molecular Weight: 813.92 Da
• Purity: >99.0% via HPLC-UV and Mass Spectrometry
• Appearance: Sterile white lyophilized cake

Reported Findings

• Enhanced Cognitive Processing: Users report significant improvements in focus, attention span, and short-term memory during intense research phases.
• Neuroprotective Resilience: Study data demonstrates reduced biomarkers of neuronal damage in models of hypoxia or oxidative stress.
• Dopaminergic Stabilization: As documented in protocols, research models show a normalizing effect on dopamine levels during fluctuating metabolic states.
• Mood and Energy Regulation: Cross-study analysis suggests improved mental clarity and reduced fatigue without the jitteriness associated with CNS stimulants.
• Optic Nerve Support: Research models have observed potential regenerative effects in specialized ocular tissues following traumatic disruption.

Key Points:
Semax represents a high-feasibility research tool for investigating the targeted modulation of neurotrophic factors and the molecular triggers of neuroplasticity.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.